Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 415.08 million. The enterprise value is 483.68 million.

Market Cap	415.08M
Enterprise Value	483.68M

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 17.66 million shares outstanding. The number of shares has increased by 1.31% in one year.

Current Share Class	17.66M
Shares Outstanding	17.66M
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.78%
Owned by Institutions (%)	52.55%
Float	12.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	18.84
PS Ratio	0.79
PB Ratio	1.92
P/TBV Ratio	n/a
P/FCF Ratio	10.50
P/OCF Ratio	9.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.82, with an EV/FCF ratio of 12.23.

EV / Earnings	-12.69
EV / Sales	0.92
EV / EBITDA	16.82
EV / EBIT	36.05
EV / FCF	12.23

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.51.

Current Ratio	1.30
Quick Ratio	0.69
Debt / Equity	0.51
Debt / EBITDA	3.87
Debt / FCF	2.81
Interest Coverage	1.89

Financial Efficiency

Return on equity (ROE) is -16.54% and return on invested capital (ROIC) is 2.35%.

Return on Equity (ROE)	-16.54%
Return on Assets (ROA)	1.62%
Return on Invested Capital (ROIC)	2.35%
Return on Capital Employed (ROCE)	4.22%
Revenue Per Employee	12.47M
Profits Per Employee	-907,262
Employee Count	42
Asset Turnover	1.01
Inventory Turnover	3.13

Taxes

In the past 12 months, Navamedic ASA has paid 9.24 million in taxes.

Income Tax	9.24M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.45% in the last 52 weeks. The beta is 0.38, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-23.45%
50-Day Moving Average	22.98
200-Day Moving Average	23.13
Relative Strength Index (RSI)	45.49
Average Volume (20 Days)	19,633

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 523.56 million and -38.11 million in losses. Loss per share was -2.16.

Revenue	523.56M
Gross Profit	191.55M
Operating Income	13.42M
Pretax Income	-28.86M
Net Income	-38.11M
EBITDA	25.67M
EBIT	13.42M
Loss Per Share	-2.16

Full Income Statement

Balance Sheet

The company has 42.66 million in cash and 111.26 million in debt, giving a net cash position of -68.60 million or -3.88 per share.

Cash & Cash Equivalents	42.66M
Total Debt	111.26M
Net Cash	-68.60M
Net Cash Per Share	-3.88
Equity (Book Value)	216.55M
Book Value Per Share	12.29
Working Capital	50.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 43.40 million and capital expenditures -3.85 million, giving a free cash flow of 39.55 million.

Operating Cash Flow	43.40M
Capital Expenditures	-3.85M
Free Cash Flow	39.55M
FCF Per Share	2.24

Full Cash Flow Statement

Margins

Gross margin is 36.59%, with operating and profit margins of 2.56% and -7.28%.

Gross Margin	36.59%
Operating Margin	2.56%
Pretax Margin	-5.51%
Profit Margin	-7.28%
EBITDA Margin	4.90%
EBIT Margin	2.56%
FCF Margin	7.55%

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	n/a
Earnings Yield	-9.18%
FCF Yield	9.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4